[PDF] Top 20 Rev. Bras. Hematol. Hemoter. vol.39 número2
Has 10000 "Rev. Bras. Hematol. Hemoter. vol.39 número2" found on our website. Below are the top 20 most common "Rev. Bras. Hematol. Hemoter. vol.39 número2".
Rev. Bras. Hematol. Hemoter. vol.39 número2
... These autoantibodies lead to platelet destruction and decreased platelet production, resulting in thrombocytopenia and bleeding symptoms.. Although the comprehension of this complex auto[r] ... See full document
3
Rev. Bras. Hematol. Hemoter. vol.39 número2
... Diagnosis of SCIC is based on clinical and laboratory evidence of non-obstructive cholestasis, moderately elevated hepatic enzymes and an enlarged and painful liver.. The patient describ[r] ... See full document
4
Rev. Bras. Hematol. Hemoter. vol.39 número2
... Furthermore, the change from supine to standing caused clinically significant increases in the hemoglobin, hematocrit, red blood cell, leukocyte, neutrophil, lymphocyte, basophil and pla[r] ... See full document
6
Rev. Bras. Hematol. Hemoter. vol.39 número2
... “Additionally, RBC alloimmunization investigations are often performed only before transfusion events and many alloanti- bodies may not be detected as no further transfusions are require[r] ... See full document
1
Rev. Bras. Hematol. Hemoter. vol.39 número2
... 1 mRNA expression in bone marrow cells from healthy donors, and from patients with multiple myeloma (MM) or plasma.. cell leukemia (PCL).[r] ... See full document
3
Rev. Bras. Hematol. Hemoter. vol.39 número2
... Some atypical and rare sickle cell gene haplotypes in populations of Andhra Pradesh, India.. Tine RC, Ndiaye M, Hansson HH, Ndour CT, Faye B, Alifrangis M, et al.[r] ... See full document
3
Rev. Bras. Hematol. Hemoter. vol.39 número2
... These recruitments have sen- sitized many to the need for bone marrow donation, and approximately 25% of the entries ( n = 956,330) in the Brazilian Bone Marrow Donor Registry (REDOME) w[r] ... See full document
3
Rev. Bras. Hematol. Hemoter. vol.39 número2
... Fanconi anemia young patients at high risk for squamous cell carcinoma. Mol Cell Pediatr.[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.39 número2
... Table 1 – World Health Organization diagnostic criteria for chronic eosinophilic leukemia.. There is no Philadelphia chromosome or breakpoint cluster region-Abelson murine leukemia (BCR-[r] ... See full document
5
Rev. Bras. Hematol. Hemoter. vol.39 número2
... Simultaneous occurrence of chronic myeloid leukemia and chronic lymphocytic leukemia: report of an unusual case. Laurenti L, Tarnani M, Nichele I, Ciolli S, Cortelezzi A, Forconi F[r] ... See full document
3
Rev. Bras. Hematol. Hemoter. vol.39 número2
... NST: nutritional support therapy; ASPEN: American Society for Parenteral and Enteral Nutrition; ESPEN: European Society for Clinical Nutrition and Metabolism; FNLCCC: Fédération National[r] ... See full document
8
Rev. Bras. Hematol. Hemoter. vol.39 número2
... Asymptomatic patients should be seen every six months with no more than a physical examination, blood counts, and bio- chemistry. The interval between visits should be shortened in cases of increasing splenomegaly or the ... See full document
9
Rev. Bras. Hematol. Hemoter. vol.39 número2
... In view of the inflammatory and oxidative stress features observed in SCD, the telomere length was determined in SCD patients and healthy controls in order to correlate this with disease[r] ... See full document
6
Rev. Bras. Hematol. Hemoter. vol.39 número2
... 6-minute walk test but patients with sickle cell anemia had a lower physical activity level.. compared to healthy controls.[r] ... See full document
7
Rev. Bras. Hematol. Hemoter. vol.39 número2
... The aim of this study was to investigate human platelet antigen frequencies in immune thrombocy- topenia patients from the state of Amazonas, Brazil and investigate the potential associa[r] ... See full document
5
Rev. Bras. Hematol. Hemoter. vol.39 número2
... Antioxidant status in beta thalassemia major: a single-center study. Boudrahem-Addour N, Izem-Meziane M, Bouguerra K, Nadjem N, Zidani N, Belhani M, et al[r] ... See full document
7
Rev. Bras. Hematol. Hemoter. vol.39 número2
... The aim of this study was to evaluate the influence of interleukin-10 polymorphisms and haplotypes on the risk of acute cerebral ischemia and high-risk transcranial Doppler in 395 childr[r] ... See full document
7
Rev. Bras. Hematol. Hemoter. vol.39 número2
... The group of blood donors included in this study was cho- sen based on all donations with positive and indeterminate results for one or more of the seven infectious markers: HBsAg, HBcAb[r] ... See full document
6
Rev. Bras. Hematol. Hemoter. vol.39 número2
... Interestingly, the magnitude of these changes were much higher in patients with edema or hypoproteinemia, in whom the mean decrease in total plasma volume was 15.7% after one hour standi[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.39 número2
... Interestingly, telomere length is a regulator of disease severity in patients harboring muta- tions in telomere biology genes, with more severe mutations causing more severe phenotypes a[r] ... See full document
2
temas relacionados